Exelixis
The Executive Director, Integrated Analytics – GI Franchise leads a team that provides advanced analytics, primary market research, real‑world data insights, and competitive intelligence to support the commercial strategy for CABOMETYX and the pending zanzalintinib launch. This senior role partners with Marketing, Sales, Market Access, Medical Affairs, and leadership to translate complex data into actionable insights that drive brand performance and competitive advantage.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
68% above the average for this role
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Executive Director, Insights and Analytics
Tango Therapeutics
Director, GI Analytics
Revolution Medicines
Director, Medical Affairs GI, Europe
Revolution Medicines
Associate Manager/Manager, Commercial Analytics – Lung Cancer
KMK Consulting, Inc.
Senior Director, Commercial Analytics, HIV Prevention Integrated Insights
Gilead Sciences
Senior Director, Global Analytics and Insights (GA&I)
AstraZeneca